Advertisement

Topics

MeVis Medical Solutions AG M3V Financial and Strategic SWOT Analysis Review [Report Updated: 12092018] Prices from USD $125

08:42 EDT 13 Oct 2018 | BioPortfolio Reports

MeVis Medical Solutions AG M3V Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.


The profile contains critical company information including:


Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.


Highlights


MeVis Medical Solutions AG MMS AG, a subsidiary of Varian Medical Systems, Inc., is a medical technology company. It develops and markets software to analyze and evaluate image data to medical device equipment manufacturers and providers of medical IT platforms. The company's software solutions are used in screening, diagnostics, therapy and intervention planning for breast, lung, colon, and prostate cancers; and neurological disorders. Its solutions portfolio includes industrial solutions; and professional solutions such as MeVis Distant services, MeVis online academy and Veolity. The company operates its Digital Mammography business through joint venture, MeVis BreastCare GmbH Co. KG. MMS AG is headquartered in Bremen, Germany.


MeVis Medical Solutions AG Key Recent Developments


Aug 21,2018: MeVis Medical Solutions announces third quarter of fiscal year results

May 15,2018: MeVis publishes figures for the second quarter of fiscal year 2017/2018

Feb 20,2018: MeVis publishes figures for the first quarter of fiscal year 2017/2018

Jan 23,2018: MeVis publishes Revenue Of 18.5 Million In The First Nine Months Of 2017

Sep 11,2017: MeVis Medical Solutions: Raising forecast for the current fiscal year


Key benefits of buying this profile include:


You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.


Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.


Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.


Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.


Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.


Note: Some sections may be missing if data is unavailable for the company

Original Article: MeVis Medical Solutions AG M3V Financial and Strategic SWOT Analysis Review [Report Updated: 12092018] Prices from USD $125

NEXT ARTICLE

More From BioPortfolio on "MeVis Medical Solutions AG M3V Financial and Strategic SWOT Analysis Review [Report Updated: 12092018] Prices from USD $125"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...